Cargando…
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains
In 2003 and 2013, the World Health Organization convened informal consultations on characterization and quality aspects of vaccines based on live virus vectors. In the resulting reports, one of several issues raised for future study was the potential for recombination of virus-vectored vaccines with...
Autores principales: | Condit, Richard C., Williamson, Anna-Lise, Sheets, Rebecca, Seligman, Stephen J., Monath, Thomas P., Excler, Jean-Louis, Gurwith, Marc, Bok, Karin, Robertson, James S., Kim, Denny, Michael Hendry, R., Singh, Vidisha, Mac, Lisa M., Chen, Robert T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204448/ https://www.ncbi.nlm.nih.gov/pubmed/27346303 http://dx.doi.org/10.1016/j.vaccine.2016.04.060 |
Ejemplares similares
-
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
por: Condit, Richard C, et al.
Publicado: (2020) -
Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines
por: Kochhar, Sonali, et al.
Publicado: (2019) -
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines
por: Kim, Denny, et al.
Publicado: (2020) -
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines
por: Gurwith, Marc, et al.
Publicado: (2020) -
Yellow fever vector live-virus vaccines: West Nile virus vaccine development
por: Arroyo, Juan, et al.
Publicado: (2001)